Skip to main content

Table 1 Baseline characteristics of study cohorts overall and within hemoglobin strata

From: Anemia and mortality in patients with nondialysis-dependent chronic kidney disease

 

Baseline ESA Nonusers

Baseline ESA Users

ESA Naives

Source population

Hb 8–10 g/dL

(N = 761)

Hb 10.1–10.5 g/dL

(N = 780)

Hb >10.5 g/dL

(N = 30,658)

All

(N = 32,199)

Hb 8–11 g/dL

(N = 79)

Hb 11.1–12.5 g/dL

(N = 30)

All

(N = 109)

Hb 8–10 g/dL

(N = 193)

Hb >10 g/dL

(N = 73)

All

(N = 266)

All

(N = 35,509)

Age (years) mean ± SD

78.6 ± 11.5

78.4 ± 11.3

76.1 ± 10.8

76.2 ± 10.8

78.1 ± 12.5

81.2 ± 7.9

78.9 ± 11.5

78.0 ± 10.7

79.1 ± 11.3

78.3 ± 10.9

76.1 ± 10.8

Sex, n (%)

 Male

228 (30.0)

220 (28.2)

11,638 (38.0)

12,086 (37.6)

31 (39.2)

9 (30.0)

40 (36.7)

79 (40.9)

23 (31.5)

102 (38.4)

13,456 (37.9)

 Female

533 (70.0)

560 (71.8)

19,020 (62.0)

20,113 (62.5)

48 (60.8)

21 (70.0)

69 (63.3)

114 (59.1)

50 (68.5)

164 (61.7)

22,053 (62.1)

Race/ethnicity, n (%)

 White

150 (19.7)

188 (24.1)

8821 (28.8)

9159 (28.4)

11 (13.9)

3 (10.0)

14 (12.8)

33 (17.1)

15 (20.6)

48 (18.1)

10,045 (28.3)

 Black

58 (7.6)

53 (6.8)

1616 (5.3)

1727 (5.4)

9 (11.4)

0

9 (8.3)

16 (8.3)

6 (8.2)

22 (8.3)

1912 (5.4)

 Hispanic

91 (12.0)

69 (8.9)

2108 (6.9)

2268 (7.0)

8 (10.1)

2 (6.7)

10 (9.2)

20 (10.4)

7 (9.6)

27 (10.2)

2425 (6.8)

 Asian

26 (3.4)

30 (3.9)

1221 (4.0)

1277 (4.0)

11 (13.9)

1 (3.3)

12 (11.0)

13 (6.7)

5 (6.9)

18 (6.8)

1410 (4.0)

CKD stage, n (%)

 3A

322 (42.3)

318 (40.8)

21,869 (71.3)

22,509 (69.9)

8 (10.1)

6 (20.0)

14 (12.8)

19 (9.8)

6 (8.2)

25 (9.4)

24,723 (69.6)

 3B

267 (35.1)

310 (39.7)

7389 (24.1)

7966 (24.7)

19 (24.1)

12 (40.0)

31 (28.4)

50 (25.9)

28 (38.4)

78 (29.3)

8829 (24.9)

 4

151 (19.8)

141 (18.1)

1343 (4.4)

1635 (5.1)

44 (55.7)

11 (36.7)

55 (50.5)

100 (51.8)

33 (45.2)

133 (50.0)

1849 (5.2)

 5

21 (2.8)

11 (1.4)

57 (0.2)

89 (0.3)

8 (10.1)

1 (3.3)

9 (8.3)

24 (12.4)

6 (8.2)

30 (11.3)

108 (0.3)

Diabetes, n (%)

449 (59.0)

466 (59.7)

12,850 (41.9)

13,765 (42.8)

55 (69.6)

20 (66.7)

75 (68.8)

128 (66.3)

45 (61.6)

173 (65.0)

15,282 (43.0)

Hypertension, n (%)

703 (92.4)

716 (91.8)

26,331 (85.9)

27,750 (86.2)

77 (97.5)

29 (96.7)

106 (97.3)

188 (97.4)

71 (97.3)

259 (97.4)

30,654 (86.3)

CHF, n (%)

312 (41.0)

264 (33.9)

6641 (21.7)

7217 (22.4)

40 (50.6)

10 (33.3)

50 (45.9)

97 (50.3)

38 (52.1)

135 (50.8)

7813 (22.0)

MI, n (%)

148 (19.5)

141 (18.1)

4428 (14.4)

4717 (14.7)

19 (24.1)

6 (20.0)

25 (22.9)

47 (24.4)

20 (27.4)

67 (25.2)

5182 (14.6)

Stroke, n (%)

141 (18.5)

136 (17.4)

4175 (13.6)

4452 (13.8)

14 (17.7)

7 (23.3)

21 (19.3)

49 (25.4)

15 (20.6)

64 (24.1)

4855 (13.7)

PVD, n (%)

282 (37.1)

269 (34.5)

7599 (24.8)

8150 (25.3)

33 (41.8)

12 (40.0)

45 (41.3)

92 (47.7)

28 (38.4)

120 (45.1)

8805 (24.8)

Albuminuria, n (%)

 <300 mg/dL

273 (35.9)

288 (36.9)

11,084 (36.2)

11,645 (36.2)

26 (32.9)

11 (36.7)

37 (33.9)

56 (29.0)

26 (35.6)

82 (30.8)

12,459 (35.1)

 ≥300 mg/dL

109 (14.3)

100 (12.8)

1575 (5.1)

1784 (5.5)

23 (29.1)

2 (6.7)

25 (22.9)

69 (35.8)

15 (20.6)

84 (31.6)

1917 (5.4)

 Not available

379 (49.8)

392 (50.2)

17,999 (58.7)

18,770 (58.3)

30 (38.0)

17 (56.7)

47 (43.1)

68 (35.2)

32 (43.8)

100 (37.6)

21,133 (59.5)

eGFR, mL/min/1.73m2, mean ± SD

40.3 ± 12.6

40.5 ± 11.8

48.3 ± 9.1

47.9 ± 9.4

27.0 ± 11.6

32.8 ± 12.0

28.6 ± 11.9

26.9 ± 11.6

29.5 ± 11.5

27.6 ± 11.6

47.8 ± 9.5

Hb, g/dL, mean ± SD

9.5 ± 0.5

10.3 ± 0.1

13.3 ± 1.4

13.2 ± 1.6

9.9 ± 0.7

11.6 ± 0.4

10.4 ± 1.0

9.2 ± 0.5

11.1 ± 1.4

9.7 ± 1.2

13.1 ± 1.6

Ferritin, ng/mL, p50 [p25, p75]

119 [40, 276]

96 [45, 185]

97 [48, 192]

98 [47, 197]

242 [138, 483]

243 [141, 319]

242 [138, 453]

242 [106, 415]

200 [96, 428]

224 [104, 418]

99 [48, 201]

TSAT, %, mean ± SD

22.7 ± 14.4

22.8 ± 11.5

26.0 ± 10.8

25.5 ± 11.3

28.7 ± 13.5

30.3 ± 15.1

29.0 ± 13.6

25.6 ± 12.2

29.8 ± 14.1

26.6 ± 12.7

25.6 ± 11.4

  1. Abbreviations: CHF congestive heart failure, CKD chronic kidney disease, CVD cerebrovascular disease, eGFR estimated glomerular filtration rate, ESA erythropoiesis-stimulating agent, Hb hemoglobin, MI myocardial infarction, PVD peripheral vascular disease, SD standard deviation, TSAT transferrin saturation, unk unknown